Çiğdem Mermutluoğlu

979 total citations
10 papers, 24 citations indexed

About

Çiğdem Mermutluoğlu is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Çiğdem Mermutluoğlu has authored 10 papers receiving a total of 24 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in Çiğdem Mermutluoğlu's work include Antifungal resistance and susceptibility (2 papers), Antibiotic Resistance in Bacteria (2 papers) and COVID-19 Clinical Research Studies (2 papers). Çiğdem Mermutluoğlu is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), Antibiotic Resistance in Bacteria (2 papers) and COVID-19 Clinical Research Studies (2 papers). Çiğdem Mermutluoğlu collaborates with scholars based in Türkiye. Çiğdem Mermutluoğlu's co-authors include Recep Tekin, Saim Dayan, Özcan Deveci, Fatma Bozkurt, Salih Hoşoğlu, Emine Parlak, Hüsnü Pullukçu, Fesih Aktar, Ali Kemal Kadiroğlu and İsmail Yıldız and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Investigative Medicine and The Journal of Infection in Developing Countries.

In The Last Decade

Çiğdem Mermutluoğlu

8 papers receiving 22 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Çiğdem Mermutluoğlu Türkiye 3 16 12 4 3 2 10 24
Candace Johnson United States 3 16 1.0× 11 0.9× 6 1.5× 3 1.0× 2 1.0× 4 26
Lulwah Alabdan Saudi Arabia 3 13 0.8× 7 0.6× 4 1.0× 2 0.7× 7 25
Irasha Harding United Kingdom 3 8 0.5× 10 0.8× 3 0.8× 3 1.0× 5 27
Kadam Patel United States 2 11 0.7× 14 1.2× 4 1.0× 2 1.0× 3 21
José Pedro Cidade Portugal 4 15 0.9× 9 0.8× 3 0.8× 3 1.5× 12 22
Alba Bergas Spain 3 6 0.4× 7 0.6× 4 1.0× 4 1.3× 2 1.0× 6 18
Nelly Daniela Zurita Spain 2 7 0.4× 11 0.9× 2 0.5× 2 0.7× 3 1.5× 3 16
Marina Varela Spain 1 11 0.7× 5 0.4× 4 1.0× 5 1.7× 2 14
Amar Shah United Kingdom 3 24 1.5× 26 2.2× 3 0.8× 2 0.7× 1 0.5× 8 38
Eugénie Mabrut France 3 16 1.0× 5 0.4× 2 0.5× 3 1.0× 1 0.5× 5 54

Countries citing papers authored by Çiğdem Mermutluoğlu

Since Specialization
Citations

This map shows the geographic impact of Çiğdem Mermutluoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Çiğdem Mermutluoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Çiğdem Mermutluoğlu more than expected).

Fields of papers citing papers by Çiğdem Mermutluoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Çiğdem Mermutluoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Çiğdem Mermutluoğlu. The network helps show where Çiğdem Mermutluoğlu may publish in the future.

Co-authorship network of co-authors of Çiğdem Mermutluoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Çiğdem Mermutluoğlu. A scholar is included among the top collaborators of Çiğdem Mermutluoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Çiğdem Mermutluoğlu. Çiğdem Mermutluoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Yamazhan, Tansu, Behice Kurtaran, Oğuz Karabay, et al.. (2023). Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data. Viral Hepatitis Journal. 29(2). 58–63.
3.
Mermutluoğlu, Çiğdem, et al.. (2023). Bruselloz Hastalarının D vitamini, Ferritin, Folik Asit ve Biyokimyasal Düzeylerinin Değerlendirilmesi. Dicle Medical Journal / Dicle Tip Dergisi. 50(4). 587–593. 1 indexed citations
4.
5.
Mermutluoğlu, Çiğdem & Recep Tekin. (2023). Evaluation of elabela, visfatin, and chemerin levels as inflammation biomarkers in COVID-19.. PubMed. 27(22). 11180–11184. 4 indexed citations
6.
Mermutluoğlu, Çiğdem, et al.. (2022). Evulation of prolidase enzyme, and galectin levels as a marker for fibrosis in patients with chronic hepatitis B.. PubMed. 26(24). 9467–9472. 1 indexed citations
7.
Mermutluoğlu, Çiğdem, Recep Dursun, Fesih Aktar, et al.. (2022). Evaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19. The Journal of Infection in Developing Countries. 16(10). 1564–1569. 1 indexed citations
8.
Mermutluoğlu, Çiğdem, Fesih Aktar, Recep Tekin, et al.. (2022). Which COVID-19 Patients Die in Intensive Care Unit (ICU) in Turkey. SHILAP Revista de lepidopterología. 49(1). 85–91. 1 indexed citations
9.
Mermutluoğlu, Çiğdem, et al.. (2017). Antifungal Susceptibility and Risk Factors in Patients with Candidemia. Eurasian Journal of Medicine. 48(3). 199–203. 11 indexed citations
10.
Mermutluoğlu, Çiğdem, Özcan Deveci, Salih Hoşoğlu, et al.. (2016). Antifungal Susceptibility and Risk Factors in Patients with Candidemia. Eurasian Journal of Medicine. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candace Johnson Breakdown of academic impact, for papers by Lulwah Alabdan Breakdown of academic impact, for papers by Irasha Harding Breakdown of academic impact, for papers by Kadam Patel Breakdown of academic impact, for papers by José Pedro Cidade Breakdown of academic impact, for papers by Alba Bergas Breakdown of academic impact, for papers by Nelly Daniela Zurita Breakdown of academic impact, for papers by Marina Varela Breakdown of academic impact, for papers by Amar Shah Breakdown of academic impact, for papers by Eugénie Mabrut
Rankless by CCL
2026